PHAP1 anticorps
Aperçu rapide pour PHAP1 anticorps (ABIN1731807)
Antigène
Voir toutes PHAP1 (ANP32A) AnticorpsReactivité
Hôte
Clonalité
Conjugué
Application
-
-
Specificité
- Reacts with synthetic peptide corresponding to amino acids at carboxy terminus of human PHAP I
-
Purification
- Antigen affinity purified
-
Immunogène
- Synthetic peptide from human ANP32A.
-
Isotype
- IgG
-
-
-
-
Indications d'application
-
Working dilution: IHC - P (10 μg/mL), WB (0.5 - 2 μg/mL)
-
Restrictions
- For Research Use only
-
-
-
Format
- Liquid
-
Concentration
- 1 mg/mL
-
Buffer
- PBS, Sodium azide 0.02 %
-
Agent conservateur
- Sodium azide
-
Précaution d'utilisation
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Stock
- 4 °C/-20 °C
-
Stockage commentaire
- Short term 4°C, long term aliquot and store at -20°C, avoid freeze thaw cycles. Store undiluted.
-
-
- PHAP1 (ANP32A) (Acidic (Leucine-Rich) Nuclear phosphoprotein 32 Family, Member A (ANP32A))
-
Autre désignation
- ANP32A
-
Sujet
- Implicated in a number of cellular processes, including proliferation, differentiation, caspase-dependent and caspase-independent apoptosis, suppression of transformation (tumor suppressor), inhibition of protein phosphatase 2A, regulation of mRNA trafficking and stability in association with ELAVL1, and inhibition of acetyltransferases as part of the INHAT (inhibitor of histone acetyltransferases) complex. Plays a role in E4F1-mediated transcriptional repression.
-
UniProt
- P39687
Antigène
-